May 2023 - BioMedWire (BMW)

WednesdayMay 31, 2023 11:34 am

Researchers ID Promising Strategy Against Immunotherapy Side Effects

Researchers from the UCLA Jonsson Comprehensive Cancer Center may have come up with a strategy that would allow them to eliminate the side effects associated with immunotherapy. Immunotherapy is a cancer treatment that leverages a patient’s own immune system to fight and kill cancer cells. It is a type of biological therapy used to treat a wide variety of cancers including breast cancer, brain cancer, bladder cancer, colorectal cancer and cervical cancer. Unfortunately, immunotherapy can also cause side effects such as fever, dizziness, weakness, joint or muscle aches and fatigue. In some cases, the treatment can cause severe side effects…

TuesdayMay 30, 2023 1:31 pm

Amazon’s $5 Monthly Plan to Deepen Giant’s Foray into Healthcare eCommerce

Amazon Prime members in the United States will soon be able to buy a variety of generic medications and enjoy doorstep delivery in exchange for a $5 monthly fee. The e-commerce giant recently announced the launch of a new program called RxPass that would grant U.S. Prime members access to more than 50 medications. Speaking to Reuters, Vin Gupta, Amazon Pharmacy chief medical officer, said that the medication provided by the platform can be used to treat more than 80 chronic conditions. These include diabetes, male pattern baldness, anxiety and high blood pressure — conditions that tend to affect a…

TuesdayMay 30, 2023 12:00 pm

BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Receives Buy Rating and $70 Target Price; Releases Q1 2023 and Business Update

Analysts at Aegis Capital Corp. continue to recommend shares of the company with a Buy rating and a $70 target price Data from pre-clinical trial indicate that BiondVax’s NanoAb may effectively serve as both a therapeutic and protective prophylactic drug, further enhancing its value proposition BVXV reiterated further NanoAb development beginning with NanoAbs targeting immune system cytokines such as IL-17 as drug candidates for the potential treatment of psoriasis and psoriatic arthritis BiondVax aims to optimize the use of assets and generate additional revenues by offering its drug development services and cGMP manufacturing capabilities to others BiondVax Pharmaceuticals (NASDAQ: BVXV),…

FridayMay 26, 2023 10:16 am

Why Adults May Develop Sudden Onset Eczema

Atopic dermatitis or eczema is a topical condition that causes patches of inflamed, dry and itchy skin. While it typically starts in childhood and becomes milder with age, some people can develop eczema as adults. Eczema can occur due to a wide variety of reasons including low humidity, dry weather, skin products, detergents and soaps, stress and even certain fabrics. Genetics also makes some people more likely to have eczema, and those individuals have a higher chance of experiencing flare-ups in response to triggers such as skin products, hormonal changes and allergens. Although it is irritating, atopic dermatitis is not…

FridayMay 26, 2023 9:00 am

NextPlat Corp. (NASDAQ: NXPL) Celebrates Great Day in Miami with More on the Way

NextPlat inks deal to provide American businesses easy access to Chinese consumer market E-Commerce Development Program in collaboration with Tmall Global announced at Miami event Tmall Global e-commerce platform will provide NextPlat customers simple turnkey solution to sell products to the Chinese consumer market First in a series of new e-commerce development programs designed to provide US businesses swift, easy e-commerce access to new international customers April 24, 2023, was a great day in Miami for NextPlat (NASDAQ: NXPL, NXPLW) and U.S. businesses eager to expand their e-commerce efforts and market goods to the multitrillion-dollar Chinese consumer market. In collaboration…

ThursdayMay 25, 2023 3:38 pm

Proton Beam Therapy Could Boost Quality of Life for Cancer Patients

Cancer is still one of the most prolific killers in the world, accounting for one in every six deaths in 2020. Treatment outcomes often depend on the type of cancer and the speed with which it is diagnosed, with some types of cancer being relatively easy to treat and others having worse health outcomes. Brain tumors tend to have some of the worse outcomes because they can infect healthy brain tissues, restrict the flow of fluid in the brain, and compress and damage other parts of the brain. Regardless, the aim of every clinician with a cancer patient is to…

ThursdayMay 25, 2023 9:00 am

BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Provides Business Update, Reports FY2022 Financial Results

Biotechnology innovator BiondVax Pharmaceuticals recently provided a business update and published full-year financial results for the period ended December 31, 2022 Achievements realized to date leave CEO Amir Reichman optimistic about the company’s growth potential and ability to deliver value to shareholders The company enjoys definitive, exclusive agreements including options for exclusive worldwide licenses with the Max Planck Society and the University Medical Center Göttingen, Germany to enable it to build a pipeline of ‘biobetter’ nanosized VHH antibodies (“NanoAbs”) Pipeline to target diseases with attractive commercial opportunities such as psoriasis, psoriatic arthritis, COVID-19, macular degeneration and asthma Biotechnology innovator BiondVax…

WednesdayMay 24, 2023 3:00 pm

New Evidence Proves Link Between Glandular Fever Virus and MS

Multiple sclerosis is a debilitating disease that damages the brain and spinal cord and often causes life-changing symptoms. It is an autoimmune disorder that occurs when the immune system mistakes the body’s tissues as hostile and begins to attack the brain and spinal cord. This causes symptoms such as cognitive dysfunction, problems with balance and mobility, and muscle weakness that could result in permanent disability in the long term. Although the exact cause of the condition is still unknown, researchers have long theorized that there may be a link between multiple sclerosis and glandular fever, an infection caused by the…

WednesdayMay 24, 2023 10:30 am

NextPlat Corp. (NASDAQ: NXPL) Inks Deal to Open Doors for US Business to ‘Mammoth’ Chinese Consumer Market

NextPlat, Tmall Global sign merchant sourcing agreement designed to give U.S. businesses easy access to Chinese e-commerce market. Tmall Global e-commerce platform will provide NextPlat customers a turnkey solution to sell products to the Chinese consumer market. Starting in Florida, NextPlat intends to expand E-Commerce Development Program businesses throughout the United States and all of the Americas. Turnkey international e-commerce solution simplifies the process, provides American-based companies opportunity of new business in China. In a collaboration designed to be the “first in a series of new e-commerce development programs,” global e-commerce provider NextPlat (NASDAQ: NXPL) and Alibaba Group Holding Limited…

TuesdayMay 23, 2023 3:32 pm

Five Trends Shaping Healthcare e-Commerce Landscape

Latest data shows that the global healthcare e-commerce market will be valued about $732 billion by the year 2027. It is expected that during this period, the healthcare industry will grow significantly. Below, we look at some of the trends that will shape this market’s future. Greater focus on automation, data and technology Businesses involved in the healthcare industry have until the end of this year to start observing requirements under the Drug Supply Chain Security Act, which entail managing data on transaction details throughout the supply chain. This data will, in addition to ensuring compliance, assist suppliers to predict…